Cyclacel Pharmaceuticals, Inc. CYCC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

39/100

2/7 Pass

SharesGrow Intrinsic Value

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Cyclacel Pharmaceuticals, Inc. (CYCC), 포함 31 건 매수 및 2 건 매도. 내부자 매수 총액은 $2.69M 내부자 매도 총액은 $42.86.

최근 활동이 있는 주요 내부자에는 Suria Sukses Engineering Sdn Bhd, Tan Kok Hui, Ho Jien Shiung. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — CYCC

날짜	이름	직책	거래 유형	주식수	평균 가격	금액	보유 주식수
2025-04-29	Suria Sukses Engineering Sdn Bhd	10 Percent Owner	알 수 없음	-	-	-	250,000
2025-04-29	Tan Kok Hui	10 Percent Owner	알 수 없음	-	-	-	250,000
2025-04-29	Ho Jien Shiung	10 Percent Owner	알 수 없음	-	-	-	250,000
2025-04-29	Ho Kee Wee	10 Percent Owner	알 수 없음	-	-	-	250,000
2025-04-29	Tan Kok Hui	Officer	알 수 없음	-	-	-	-
2025-04-29	Suria Sukses Engineering Sdn Bhd	Officer	알 수 없음	-	-	-	-
2025-04-29	Ho Jien Shiung	Officer	알 수 없음	-	-	-	-
2025-04-29	Ho Kee Wee	Officer	알 수 없음	-	-	-	-
2025-04-02	Nair Krishnan Satis Waran	Director	알 수 없음	-	-	-	-
2025-04-02	Laurduraj Inigo Angel	Director	알 수 없음	-	-	-	-
2025-02-26	Natan David	Director	RSU 부여	700,000	$0.33	$231K	700,000
2025-02-26	Kiu Cu Seng	CFO and Secretary	알 수 없음	-	-	-	-
2025-02-26	Doris Wong Sing Ee	10 Percent Owner, Officer: Chief Executive Officer	알 수 없음	-	-	-	194,628,820
2025-02-26	Chong Kwang Fock	Director	알 수 없음	-	-	-	-
2025-02-26	Lazar David E.	10 Percent Owner, Officer: Interim CEO	옵션 행사 (매도)	1,000,000	-	-	-
2025-02-26	Ben-tzvi Avraham	Director	RSU 부여	700,000	$0.33	$231K	700,000
2025-02-06	Lazar David E.	10 Percent Owner, Officer: Interim CEO	RSU 부여	2,100,000	-	-	2,100,000
2025-01-05	Ben-tzvi Avraham	Director	알 수 없음	-	-	-	-
2025-01-02	Natan David	Director	알 수 없음	-	-	-	-
2025-01-02	Natan David	Director	RSU 부여	100,000	-	-	100,000
2025-01-02	Lazar David E.	Chief Executive Officer	알 수 없음	2,650,000	-	-	-
2024-01-29	Schwartz Brian	Interim Chief Medical Officer	RSU 부여	12,500	$2.28	$28.5K	12,500
2023-12-21	Rombotis Spiro George	President and CEO	정보 매수	6,070	$3.19	$19.36K	6,070
2023-12-21	Mcbarron Paul	See Remarks	정보 매수	1,886	$3.19	$6.02K	1,886
2023-06-30	Barker Sam L	Director	RSU 부여	21,219	-	-	40,415
2023-06-30	Henney Christopher S	Director	RSU 부여	21,219	-	-	39,415
2023-06-30	Rombotis Spiro George	President and CEO	RSU 부여	110,000	$0.59	$64.8K	110,000
2023-06-30	Mcbarron Paul	See Remarks	RSU 부여	70,200	$0.59	$41.35K	70,200
2023-06-30	Schwartz Brian	Director	RSU 부여	21,219	-	-	40,602
2023-06-30	Spiegel Robert J.	Director	RSU 부여	21,219	-	-	39,415
2023-06-30	Walker Karin L	Director	RSU 부여	21,219	-	-	40,602
2023-06-30	Kirschbaum Mark	Chief Medical Officer	RSU 부여	70,200	$0.59	$41.35K	70,200
2023-06-30	Ferguson Kenneth M.	Director	RSU 부여	42,438	$0.59	$25K	42,438
2023-01-31	Rombotis Spiro George	President and CEO	RSU 부여	57,600	-	-	62,588
2023-01-31	Mcbarron Paul	See Remarks	RSU 부여	31,200	-	-	31,492
2023-01-31	Kirschbaum Mark	Chief Medical Officer	RSU 부여	31,200	-	-	31,200
2022-06-14	Barker Sam L	Director	RSU 부여	15,822	-	-	19,196
2022-06-14	Henney Christopher S	Director	RSU 부여	15,822	-	-	18,196
2022-06-14	Schwartz Brian	Director	RSU 부여	15,822	-	-	19,383
2022-06-14	Sems Lloyd	Director	RSU 부여	15,822	-	-	18,196
2022-06-14	Spiegel Robert J.	Director	RSU 부여	31,645	-	-	31,645
2022-06-14	Walker Karin L	Director	RSU 부여	31,645	-	-	31,645
2022-06-14	Ferguson Kenneth M.	Director	알 수 없음	-	-	-	-
2022-06-14	Ferguson Kenneth M.	Director	RSU 부여	27,733	-	-	27,733
2022-06-14	Ferguson Kenneth M.	Director	RSU 부여	23,733	-	-	23,733
2021-12-13	Rombotis Spiro George	President and CEO	RSU 부여	190,000	$3.45	$655.5K	190,000
2021-12-13	Mcbarron Paul	See Remarks	RSU 부여	100,000	$3.45	$345K	100,000
2021-12-13	Kirschbaum Mark	Chief Medical Officer	RSU 부여	100,000	$3.45	$345K	100,000
2021-12-13	Rombotis Spiro George	President and CEO	RSU 부여	190,000	$3.45	$655.5K	190,000
2021-11-30	Barker Sam L	Director	정보 매도	12	$3.57	$42.86	3,374